MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ICPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intercept Pharmaceuticals (ICPT) Ownership - Who owns Intercept Pharmaceuticals?

Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
305 Madison Avenue
Phone
+1 646 747-1000
Employees
341
Web
https://www.interceptpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
794.69M
P/E Ratio
N/A
Total Cash
322.71M
Projected Growth
N/A
Total Debt
223.86M
Revenue
317.68M
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash/Share
7.72
Total Debt/Equity
N/A
Revenue/Share
7.62 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ICPT
A.I. Advisor
published General Information

General Information

a developer of therapeutics for the treatment of chronic fibrotic and metabolic diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
305 Madison Avenue
Phone
+1 646 747-1000
Employees
341
Web
https://www.interceptpharma.com